Check your eligibility now & get in touch with a study center
CHECK ELIGIBILITY
Email
Download
Print

Test Food4GutMarKIT - Evaluation of a Tailored Personalized Food Concept for a Healthy Gut Microbiota and Validation of Biomarkers for Monitoring of Its Effects

The overall test test test test aim in this "proof-of-concept" study is to evaluate if a diet concept, based on foods that have individually been reported to beneficially affect gut microbiota in fact has an effect on gut microbiota composition and activity among healthy and obese subjects and whether the effects are associated with altered cardiometabolic risk factors. The aim is further to investigate if such alterations are reflected in changes of the fecal and plasma metabolome. In total, 40 men and women, who meet all the inclusion criteria and none of the exclusion criteria will be invited to participate in the study. The participants will follow an intervention diet for 6 weeks and a control diet for 6 weeks, with a 6-week wash-out period in between and will be randomized to either begin with the intervention diet or the control diet.
The study will be running over 18 weeks (including a 6-week wash-out period) and it will include 9 visits at the clinic.

Highlighted Text Block

You can use content blocks to arrange your articles, large texts, instructions. Combine these blocks with media blocks to add illustrations and video tutorials. You can use various content blocks to work with your text. Add quotations, lists, buttons. Select your text to change its formatting or add links. You can use various content blocks to work with your text. Add quotations, lists, buttons. Select your text to change its formatting or add links.
Email
Download
Print

About the Clinical Trials

Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis vitae commodo. Duis ornare bibendum.

Feature One

Class aptent taciti ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis vitae.

Feature Two

Class aptent taciti ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis vitae.

Feature Three

Class aptent taciti ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis vitae.

Feature Four

Class aptent taciti ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis vitae.

Pursuing progress against advanced prostate cancer

Joining a clinical trial is an important and personal decision. Your doctor may have mentioned the TALAPRO-3 study, or perhaps you found your way here by yourself. To qualify for this study, you may not have received certain anti-cancer treatments, such as:
  • platinum-based chemotherapy within the past 5 years
  • a novel hormone therapy (NHT), such as enzalutamide, or abiraterone/prednisone, or apalutamide if taken for more than 3 months
  • a PARP inhibitor (PARPi)
  • androgen deprivation treatment for more than 3 months
Condition
metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Age
18+ years
Number of study visits
Upto 25
Length of study
About 3 years

Diabetes

What is Diabetes?
A large percentage of viewers are on mobile devices, so keep it short and to the point. Have you ever noticed how long a 5 sentence paragraph looks on a smart phone? If you read it via desktop/laptop, you realize it is really not that much information. A suggestion is to plan on “marrying” the two and keep the chatter down. Conversely, don’t sacrifice the “meat and potatoes” of what you’re trying to convey; this will help to keep the organic SEO strong.
What causes Diabetes?
Viewers need to be given a direction every now and then. Use your headers to draw the eye where you want it. Imagine the website as a term paper and your outline will guide your structure. Focus broad topics on the main headers and help guide the viewer down the right path! Appropriately introducing call-to-action buttons also helps with guiding the reader and connecting content writing with your website’s goal.
How is Diabetes treated?
Here are a few website content writing tips to make sure your website content gets the attention it deserves • Know your audience • Write short, simple sentences – Nix the jargon – Mix up your word choice • Make text scannable • Incorporate multimedia Capturing reader’s interests with good website content and information can be challenging. Most visitors will spend just a few seconds on a webpage, before deciding what to do next. Therefore, good website writing is the key to beating these odds.
More information about Diabetes
National Diabetes Foundation National Diabetes Foundation – Support Network American Academy of Diabetes International Diabetes Council International Federation of Diabetes Associations

Call 1800-9860-568 now to find out if you are eligible.

Are you a patient with moderate to severe plaque psoriasis?

Have you treated your condition with adalimumab (Humira®) and did it become less effective on your plaque psoriasis within the last 6 months? If so, you may be eligible for a clinical research study with etanercept (Enbrel®) which is also approved for moderate to severe plaque psoriasis. Qualified participants will receive an initial consultation, study-related examinations, and study medication.

Are you a patient with moderate to severe plaque psoriasis?

Have you treated your condition with adalimumab (Humira®) and did it become less effective on your plaque psoriasis within the last 6 months? If so, you may be eligible for a clinical research study with etanercept (Enbrel®) which is also approved for moderate to severe plaque psoriasis. Qualified participants will receive an initial consultation, study-related examinations, and study medication.
content image
Diabetes
A short sentence to introduce what to expect in the about condition section
Learn more
The Study
A short sentence to introduce what to expect in the about condition section
Learn more
About Clinical Trials
A short sentence to introduce what to expect in the about condition section
Learn more

Are you a patient with moderate to severe plaque psoriasis?

Have you treated your condition with adalimumab (Humira®) and did it become less effective on your plaque psoriasis within the last 6 months? If so, you may be eligible for a clinical research study with etanercept (Enbrel®) which is also approved for moderate to severe plaque psoriasis. Qualified participants will receive an initial consultation, study-related examinations, and study medication.
content image
content image

Are you a patient with moderate to severe plaque psoriasis?

Have you treated your condition with adalimumab (Humira®) and did it become less effective on your plaque psoriasis within the last 6 months? If so, you may be eligible for a clinical research study with etanercept (Enbrel®) which is also approved for moderate to severe plaque psoriasis. Qualified participants will receive an initial consultation, study-related examinations, and study medication.
content image